TCH is a chemotherapy regimen consisting of Taxotere (docetaxel), carboplatin and Herceptin (trastuzumab), which is used to treat breast cancer.
| TCH | |
|---|---|
| Specialty | Oncology |
References
edit | This oncology article is a stub. You can help Wikipedia by expanding it. |